Prostate screening important for men as they age

Approximately one in eight men in the United States will be diagnosed with prostate cancer in his lifetime? This disease is a leading cause of cancer death in men. Today we will discuss the importance of prostate screening for men as they age.

Prostate screening important for men as they age

This is a fact, even though prostate cancer is the second leading cause of cancer death in American men behind only lung cancer,” said Dr. Mohsen Isaacs, MD, medical director of radiation oncology at Monongahela Valley Hospital.

Issac said that about one in 41 men will die of prostate cancer.

US The Preventive Task Force recommends that men under the age of 40 not need routine screening for prostate cancer unless they have a family history of the disease.

At age 45, high-risk categories should be screened – this includes African American men and a father or brother diagnosed at an early age.

At age 50, men who are at average risk of prostate cancer, and are expected to live at least 10 more years, should have regular screening.

PSA Screening

Prostate cancer is usually diagnosed by performing a blood test for an oncologic biomarker called prostate specific antigen, or PSA, which is produced by the glandular epithelium of the prostate.

“Other factors can affect PSA such as infection, inflammation, urinary retention, advanced age and benign prostate enlargement,” Isaacs said. “So even though the PSA is not a perfect test, there is a way to improve the PSA for prostate cancer diagnosis with features such as PSA density, PSA velocity, percentage of free PSA and age specific thresholds instead of a cutoff value of 4.

The US Preventive Task Force revised its PSA screening in 2013 based on a study comparing it to a digital rectal exam. The study found no significant difference in death when adding PSA to the usual standard of care.

Prostate cancer

“Maybe in the past we treated patients with prostate cancer,” Isaacs said. “But we can use better and age specific thresholds of PSA and perhaps add new biomarkers to aid in the selection of biopsies so that we can avoid unnecessary prostate biopsies.”

Isaacs said that using prostate MRI fusion for more accurate biopsies, as well as helping to better define the risks with genomic testing, may be better courses of action for physicians.

“Even if you can be diagnosed with prostate cancer, it doesn’t mean that patients have to be treated, but watchful waiting can better evaluate them,” he said.

Free screening event

Prostate cancer can be a serious disease, but most men with prostate cancer do not die from it. In fact, more than 3.1 million men in the United States who have been diagnosed with prostate cancer at some point are still alive today. To help promote screening, MVH is offering a free prostate screening program at 5 p.m. 6 October Anthony M. At the Lombardy Education Conference Center. Attendees will learn about the importance of early detection and will have the option of receiving an examination by MVH’s medical staff along with a prostate specific antigen (PSA) blood test.

“Early-stage prostate cancer has no obvious symptoms and that’s what makes it a silent killer,” Isaacs said. “When it progresses, it can cause symptoms such as increased frequency of urination, urgency of urine, and hematuria (blood in the urine). Sometimes prostate cancer can spread to the bones causing bone pain. “

Treatment options

The earlier the stage of prostate cancer, the more treatment options are available to treat the condition.

“First, they have to be diagnosed by prostate biopsy,” Isaacs said. “Treatment options vary from watchful waiting (based on age, risk factors and pathology reports), to surgery or radiation therapy. Sometimes hormone therapy may be added to radiation therapy to improve patient outcome.”

Isaacs said that prostate cancer is a very live form of cancer if it is diagnosed early.

“But still, prostate cancer is the second leading cause of cancer death for men in the United States because the biology of prostate cancer is not the same for all men,” he said.

The MVH free screening program is for men aged 50-75 who have not already been diagnosed with prostate problems. Appointments are limited and advance registration is required. Free parking will be arranged


Leave a Reply

Your email address will not be published.